Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sanofi-Aventis Asia Pacific R&D Head Frank Jiang On Opportunities In China And India: An Interview With PharmAsia News (Part 1 of 2)

This article was originally published in PharmAsia News

Executive Summary

Sanofi-Aventis VPand Head, Asia PacificR&D Frank Jiang talked to PharmAsia News along the sidelines of the recent DIA China conference in Beijing. Jiang shared his vision of how the company is revamping its R&D strategies in Asia to bring more therapies to patients in India and China.
Advertisement

Related Content

Quick Take: AstraZeneca Pursues Traditional Chinese Medicine As New Source For R&D
GSK Establishes Discovery Unit For Traditional Chinese Medicine
Traditional Chinese Medicines Seen As Global Growth Opportunity
Traditional Chinese Medicines Seen As Global Growth Opportunity
Sanofi-Aventis Asia Pacific R&D Head Frank Jiang Sees Progress And Promise In Research Alliances Across China
Sanofi-Aventis Asia Pacific R&D Head Frank Jiang Sees Progress And Promise In Research Alliances Across China
Sanofi-Aventis Asia Pacific R&D Head Frank Jiang On Opportunities In China And India: An Interview With PharmAsia News (Part 2 of 2)
Sanofi-Aventis Enters First R&D Pact In India For Glenmark's Pain Drugs; Instills Optimism In India's R&D Capabilities
Sanofi-Aventis China R&D Head Frank Jiang On Fast And Furious Adaptation In China: An Interview With PharmAsia News (Part 2 of 2)
Sanofi-Aventis China R&D Head Frank Jiang On Fast And Furious Adaptation In China: An Interview With PharmAsia News (Part 2 of 2)
Advertisement
UsernamePublicRestriction

Register

SC075671

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel